At Home Partnering with LLS for Blood Cancer Awareness Month

The major home decor superstore will be partnering with the LLS to raise money and awareness during Blood Cancer Awareness Month.

Home decor superstore At Home is announcing a national fundraising and awareness raising partnership with The Leukemia & Lymphoma Society (LLS). During Blood Cancer Awareness Month (September), At Home team members will be collecting $1, $5 and $10 donations at the check-out registers at more than 75 locations across the U.S.

At Home will also be sponsoring Champion-level participation in this year's LLS Light The Night Walk for full and part-time team members nationwide.

"We are proud to announce our partnership with The Leukemia & Lymphoma Society and support the great work they are doing in the fight against blood cancers," said Lee Bird, CEO of At Home. "This national fundraising campaign reinforces one of our core values as a company - doing the right thing for the communities in which we live and work. At Home is known for providing our customers with endless home decor possibilities to express their personal style, and now we are giving them a chance to express their generosity as well. We are very grateful for their support and we look forward to seeing our team members and customers come together and support this worthy cause."

"The donations that At Home raises through its efforts inside and outside of their stores will help fund lifesaving blood cancer research," said Louis J. DeGennaro, Ph.D., interim president & CEO and chief mission officer for The Leukemia & Lymphoma Society. "LLS exists to find cures for blood cancer patients and ensure that patients have access to lifesaving treatments. We've made great progress, but there is still work to be done. As there are no means of screening for, or preventing most blood cancers, we must focus on cures. We are grateful for the support of At Home to help us reach our goal of a world without blood cancers."

Source: PR Newswire

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap